Syndrome News and Research

RSS

Evolution of SARS-CoV-2 variants

Research has demonstrated the evolutionary process and biology of SARS-CoV-2, the causative pathogen of the COVID-19 pandemic.

21 Apr 2022

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Researchers investigated the effect of binding antibodies on SARS-CoV-2 Omicron breakthrough infections.

21 Apr 2022

Researchers conduct SARS-CoV-2 risk assessment with regard to wildlife research, rehabilitation, and control

In a new study, risk assessments for research, survey, monitoring, management, wildlife rehabilitation, and wildlife control were updated regarding SARS-CoV-2.

21 Apr 2022

Study evaluates the use of a diagnostic code for Long COVID

Researchers evaluated the use of U09.9, a CD-10-CM code described as 'Post coronavirus disease 2019 (COVID-19) condition, unspecified' for post-acute COVID-19 sequelae (long COVID).

21 Apr 2022

Study evaluates SARS-CoV-2 whole genome data from patients and staff in the VA Northeast Ohio Healthcare System

Researchers surveyed over 360 COVID-19 patients to characterize the SARS-CoV-2 genomic sequence diversity of individual infections.

21 Apr 2022

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

Researchers developed an immunoantiviral, NanoSTING, and demonstrated its broad-spectrum antiviral properties in hamsters and mice.

21 Apr 2022

New insight into SARS-CoV-2 main protease opens door to new viral inhibitors

A recent study has revealed a full cycle of substrate cleavage for the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – providing, in turn, a steadfast foundation for developing potent new viral inhibitors. The paper was published in the journal Proceedings of the National Academy of Sciences (PNAS).

20 Apr 2022

Study examines vitamin D and COVID-19 media coverage in the U.K.

A new study investigates the relationship between COVID-19 and vitamin D that has been presented in traditional media sources like U.K. newspapers.

20 Apr 2022

Advancements in HIV science

As far as viruses go, human immunodeficiency virus (HIV) is quite simple. About 100,000 times smaller than a red blood cell, the virus expresses just a dozen proteins, yet it can establish a lifelong infection that, if left untreated, causes acquired immunodeficiency syndrome (AIDS) and death.

20 Apr 2022

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

A new study published in PLoS ONE characterizes the antibody response to BNT162b2, the Pfizer-BioNTech COVID-19 vaccine

20 Apr 2022

Novel saliva immunoassays to detect prior SARS-CoV-2 infection

Six salivary ELISAs were developed to evaluate the immune response to SARS-CoV-2 and estimate rates of past infection.

20 Apr 2022

Investigating the impact of SARS-CoV-2 Omicron spike mutations

Researchers investigated the impact of amino acid substitutions of SARS-CoV-2 Omicron on spike protein function, processing, and neutralization susceptibility.

20 Apr 2022

Polyethylene glycol-specific antibody responses induced by mRNA-1273 COVID-19 vaccine

Researchers determined the impact of COVID-19 vaccines on polyethylene glycol-specific antibody responses.

20 Apr 2022

Study investigates co-metabolism during SARS-CoV-2 infection

In a new study, researchers investigated host-virus co-metabolism during a SARS-CoV-2 infection.

20 Apr 2022

Exploring the vaccine effectiveness of COVID-19 booster vaccine doses

In a new study, researchers compared the effectiveness of the COVID-19 booster vaccine to that of the primary vaccine series.

20 Apr 2022

The impact of COVID-19 vaccine hesitancy and resistance on the population of England

A study conducted by the UK Health Security Agency has recently estimated the rate of hospitalization and death due to COVID-19 among unvaccinated persons residing in England.

20 Apr 2022

Waning antibody responses in SARS-CoV-2-infected children and adults over time

In a new study, researchers evaluated the duration of antibodies against SARS-CoV-2.

20 Apr 2022

Study evaluates community-level influences on COVID-19 incidence in England and their variations over time

Researchers assessed community-level impacts on SARS-CoV-2 prevalence in England.

20 Apr 2022

Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

In a new study, researchers assessed the impact of the SARS-CoV-2 Omicron variant on infected human cells and organs.

20 Apr 2022

Study demonstrates subset of vaccine-induced HLA-A*24:02-restricted T cells exhibits enhanced reactivity against the Omicron BA.1 variant

Researchers characterized vaccine-induced T cell response specific for spike proteins of several SARS-CoV-2 variants.

20 Apr 2022

Syndrome News and Research

Evolution of SARS-CoV-2 variants

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Researchers conduct SARS-CoV-2 risk assessment with regard to wildlife research, rehabilitation, and control

Study evaluates the use of a diagnostic code for Long COVID

Study evaluates SARS-CoV-2 whole genome data from patients and staff in the VA Northeast Ohio Healthcare System

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

New insight into SARS-CoV-2 main protease opens door to new viral inhibitors

Study examines vitamin D and COVID-19 media coverage in the U.K.

Advancements in HIV science

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

Novel saliva immunoassays to detect prior SARS-CoV-2 infection

Investigating the impact of SARS-CoV-2 Omicron spike mutations

Polyethylene glycol-specific antibody responses induced by mRNA-1273 COVID-19 vaccine

Study investigates co-metabolism during SARS-CoV-2 infection

Exploring the vaccine effectiveness of COVID-19 booster vaccine doses

The impact of COVID-19 vaccine hesitancy and resistance on the population of England

Waning antibody responses in SARS-CoV-2-infected children and adults over time

Study evaluates community-level influences on COVID-19 incidence in England and their variations over time

Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

Study demonstrates subset of vaccine-induced HLA-A*24:02-restricted T cells exhibits enhanced reactivity against the Omicron BA.1 variant

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News